News Center - Luye Life Sciences

News Center

Boan Biotech Announces 2026 Interim Results

2026-08-28 MORE>
Boan Biotech Submits BLA for Aflibercept Intravitreous Injection in Brazil

2026-08-06 MORE>
Luye Pharma Announces Positive Phase 2 Results of LY03015, a VMAT2 Inhibitor and Sigma-1R ...

2026-06-17 MORE>
Luye Medical’s Aurora Healthcare Partners with Tencent Health to Bring AI-Powered Care to...

2026-05-28 MORE>
Boan Biotech’s Boluojia® Newly Approved in China for Treating Bone Metastases from Solid ...

2026-05-28 MORE>
Luye Pharma Announces First Subject Enrolled in U.S. PK Bridging Clinical Trial of Its VMA...

2026-04-22 MORE>

共150项 / 25页首页上一页 1 2 3 4 5 下一页尾页

鲁ICP备05023892号-5 LUYE All Rights Reserved Privacy policy Terms of use

TOP